Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P0CG08

Entry ID Method Resolution Chain Position Source
AF-P0CG08-F1 Predicted AlphaFoldDB

210 variants for P0CG08

Variant ID(s) Position Change Description Diseaes Association Provenance
rs377651969
CA29913319
5 I>N No ClinGen
ESP
TOPMed
gnomAD
CA1066206
rs781949323
6 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA1066205
rs140594340
6 D>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1231307317
CA342215453
7 S>P No ClinGen
TOPMed
CA342215464
rs1319907049
8 S>G No ClinGen
TOPMed
CA342215501
rs782226540
10 M>L No ClinGen
ExAC
TOPMed
gnomAD
CA342215510
rs1553246487
10 M>T No ClinGen
gnomAD
CA1066207
rs782226540
10 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1359299720
CA342215546
12 T>I No ClinGen
TOPMed
gnomAD
rs1571205251
CA342215539
12 T>P No ClinGen
Ensembl
TCGA novel 13 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1066208
rs782371724
13 S>T No ClinGen
ExAC
gnomAD
rs1571205298
CA342215561
13 S>Y No ClinGen
Ensembl
rs368374809
CA1066228
15 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA342216403
rs1485592330
15 I>V No ClinGen
TOPMed
CA1066229
rs587632867
16 L>P No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 18 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1351486989 19 G>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1260255598
CA342216435
20 F>L No ClinGen
TOPMed
CA1066230
rs782184239
22 W>R No ClinGen
ExAC
TOPMed
gnomAD
CA342216460
rs1553247955
23 L>F No ClinGen
gnomAD
CA342216471
rs1342505755
COSM1294958
24 F>L Variant assessed as Somatic; impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs1553247959
CA342216488
26 M>I No ClinGen
gnomAD
rs587718844
CA1066231
27 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs781958553
CA1066232
27 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs587718844
CA342216489
27 R>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA342216543
rs1553247974
33 Y>* No ClinGen
gnomAD
TCGA novel 34 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA29915773
rs200669915
35 I>M No ClinGen
Ensembl
rs781906653
CA1066245
36 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs587629056
CA1066246
36 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA342216587
rs1553248395
37 Q>H No ClinGen
gnomAD
rs782588706
CA1066247
38 Y>S No ClinGen
ExAC
gnomAD
rs201862480
CA1066248
41 Q>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1553248401
CA342216628
44 F>L No ClinGen
gnomAD
CA1066251
rs782632071
46 V>M No ClinGen
ExAC
gnomAD
rs375851990
CA1066252
47 T>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs782408142
CA1066253
48 F>L No ClinGen
ExAC
gnomAD
rs781913248
CA1066254
49 A>P No ClinGen
ExAC
TOPMed
gnomAD
rs782193444
CA1066255
53 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA342216698
CA342216700
rs1553248415
54 M>I No ClinGen
gnomAD
CA342216715
rs1553248417
56 E>D No ClinGen
gnomAD
rs1357293281
CA342216721
57 L>P No ClinGen
TOPMed
gnomAD
CA342216725
rs1394933892
58 I>L No ClinGen
TOPMed
CA342216731
rs1399518858
59 I>V No ClinGen
TOPMed
rs1457463831
CA342216773
65 V>I No ClinGen
TOPMed
gnomAD
rs781968148
CA1066257
67 N>D No ClinGen
ExAC
TOPMed
gnomAD
rs782001707
CA1066275
70 S>F No ClinGen
ExAC
gnomAD
rs782272012
CA1066276
71 R>C No ClinGen
ExAC
gnomAD
CA1066277
rs782414733
71 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA342216847
rs1197756841
72 Y>C No ClinGen
TOPMed
TCGA novel
rs1553249209
CA342216880
75 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
gnomAD
CA342216874
rs1553249207
75 W>R No ClinGen
gnomAD
rs782064435
CA342216936
79 L>P No ClinGen
ExAC
TOPMed
gnomAD
rs782064435
CA1066279
79 L>R No ClinGen
ExAC
TOPMed
gnomAD
rs142935665
CA342216948
80 C>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1066281
rs375267760
82 I>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs782121023
CA1066282
84 L>V No ClinGen
ExAC
gnomAD
rs139258514
CA1066283
89 M>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA342217047
rs1258024168
91 P>T No ClinGen
TOPMed
rs1553249236
CA342217064
92 F>L No ClinGen
gnomAD
rs1194128331
CA342217061
92 F>S No ClinGen
TOPMed
CA342217073
rs1553249238
93 Y>C No ClinGen
gnomAD
rs781891808
CA1066285
95 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA1066286
rs782570069
96 Y>C No ClinGen
ExAC
gnomAD
TCGA novel 96 Y>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 96 Y>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA342217114
rs1553249255
97 F>I No ClinGen
gnomAD
CA1066288
rs781878942
100 S>R No ClinGen
ExAC
gnomAD
CA342217170
rs1368446714
102 I>V No ClinGen
TOPMed
CA1066289
rs145261510
103 R>* No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA342217186
rs782621260
103 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA1066290
rs782621260
103 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA342217192
rs782459478
104 L>P No ClinGen
ExAC
TOPMed
gnomAD
rs782459478
CA1066292
104 L>Q No ClinGen
ExAC
TOPMed
gnomAD
rs370678417
CA342217195
105 L>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA342217254
rs1217555015
106 H>P No ClinGen
TOPMed
rs1359393049
CA342217280
108 Q>* No ClinGen
TOPMed
rs1359393049
CA342217277
108 Q>K No ClinGen
TOPMed
rs782210342
CA1066318
108 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA1066319
rs143821798
109 R>* No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1066320
rs782562694
109 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs782401775
CA1066324
113 S>P No ClinGen
ExAC
gnomAD
rs1403166719
CA342217351
117 W>* No ClinGen
TOPMed
rs782342661
CA1066327
117 W>L No ClinGen
ExAC
gnomAD
rs781943877
CA1066328
118 L>P No ClinGen
ExAC
gnomAD
CA1066329
rs782055663
119 T>A No ClinGen
ExAC
gnomAD
rs1571236950
CA342217391
121 M>L No ClinGen
Ensembl
CA342217395
rs1417566360
121 M>T No ClinGen
TOPMed
gnomAD
CA1066332
rs587766922
123 F>L No ClinGen
1000Genomes
ExAC
gnomAD
CA1066331
rs781888365
123 F>V No ClinGen
ExAC
gnomAD
rs201402961
CA1066334
128 G>* No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA342217482
rs1553249406
128 G>E No ClinGen
gnomAD
CA342218312
rs1478361598
143 I>V No ClinGen
TOPMed
TCGA novel 144 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1275679187
CA342218426
149 R>Q No ClinGen
TOPMed
rs1484140509
CA342218424
149 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA342218459
rs1203540950
151 G>R No ClinGen
TOPMed
rs1303245787
CA342218510
153 I>T No ClinGen
TOPMed
CA342218650
rs1366241609
161 L>I No ClinGen
TOPMed
rs1366241609
CA342218653
161 L>V No ClinGen
TOPMed
CA342218783
rs1350720653
168 N>S No ClinGen
TOPMed
rs1461736582
CA342218828
172 T>A No ClinGen
TOPMed
rs1353130532
CA342218834
172 T>I No ClinGen
TOPMed
rs1178804540
CA342218864
174 M>L No ClinGen
TOPMed
rs1415575711
CA342218886
174 M>T No ClinGen
TOPMed
CA342219066
rs1390794839
179 R>S No ClinGen
TOPMed
CA342219164
rs1318386249
184 T>M No ClinGen
TOPMed
CA342219239
rs1405342799
189 L>V No ClinGen
TOPMed
rs1164643710
CA342219253
190 E>Q No ClinGen
TOPMed
rs1386273583
CA342219278
191 R>Q No ClinGen
TOPMed
CA342219271
rs1446765212
191 R>W No ClinGen
TOPMed
rs1183475272
CA342219287
192 R>Q No ClinGen
TOPMed
rs1250503913
CA342219321
194 L>P No ClinGen
TOPMed
rs1553251401
CA342219331
195 Q>* No ClinGen
Ensembl
CA342219374
rs1216584124
197 M>V No ClinGen
TOPMed
CA342219433
rs1446503249
199 M>V No ClinGen
TOPMed
rs1282349689
CA342219540
204 K>M No ClinGen
TOPMed
rs1370082651
CA342219741
208 A>T No ClinGen
TOPMed
rs1323810434
CA342219758
209 M>V No ClinGen
TOPMed
CA342219806
rs1448345482
210 A>T No ClinGen
TOPMed
rs1169284223
CA342219824
211 R>Q No ClinGen
TOPMed
CA342219823
rs1354668985
211 R>W No ClinGen
TOPMed
rs1571285823
CA342219854
213 T>K No ClinGen
Ensembl
CA342219860
rs1407899085
214 M>V No ClinGen
TOPMed
rs1426867703
CA342219921
217 K>E No ClinGen
TOPMed
rs1454993389
CA342220008
220 V>M No ClinGen
TOPMed
CA342220038
rs1252848773
221 H>R No ClinGen
TOPMed
rs1203947122
CA342220117
226 G>D No ClinGen
TOPMed
rs1305930899
CA342220250
235 T>I No ClinGen
TOPMed
CA342220415
rs1209430990
245 T>A No ClinGen
TOPMed
rs1328664982
CA342220419
245 T>I No ClinGen
TOPMed
TCGA novel 249 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA342220481
rs1266439835
250 E>K No ClinGen
TOPMed
rs1235423622
CA342220491
251 V>L No ClinGen
TOPMed
TCGA novel 256 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1242345523
CA342220647
261 L>F No ClinGen
TOPMed
rs1328068744
CA342220706
265 T>I No ClinGen
TOPMed
rs1321204194
CA342220742
268 L>V No ClinGen
TOPMed
CA342220778
rs1385850178
271 T>S No ClinGen
TOPMed
TCGA novel 273 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1386375722
CA342220847
274 R>G No ClinGen
TOPMed
CA342221006
rs1309550047
284 K>R No ClinGen
TOPMed
TCGA novel 291 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA342221285
rs1369858400
297 C>R No ClinGen
TOPMed
TCGA novel 301 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1282711781
CA342388357
304 A>T No ClinGen
TOPMed
rs1434489339
CA342388372
305 T>A No ClinGen
TOPMed
rs1337618514
CA342388382
305 T>I No ClinGen
TOPMed
CA342388387
rs1409634730
306 I>V No ClinGen
TOPMed
CA342388471
rs1394022912
310 F>L No ClinGen
TOPMed
TCGA novel 310 F>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 312 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1470231180
CA342388486
312 R>G No ClinGen
TOPMed
rs1428579054
CA342388489
312 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA342388496
rs1173624652
313 V>I No ClinGen
TOPMed
CA342388546
rs1470841095
316 T>M No ClinGen
TOPMed
TCGA novel 318 P>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1180586706
CA342388576
318 P>S No ClinGen
TOPMed
rs1435749018
CA342388609
321 R>G No ClinGen
TOPMed
CA342388619
rs1236708314
321 R>K No ClinGen
TOPMed
TCGA novel 324 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA342388679
rs1206032855
325 I>N No ClinGen
TOPMed
CA342388696
rs1324884811
326 T>I No ClinGen
TOPMed
CA342388762
rs1262993666
332 I>L No ClinGen
TOPMed
TCGA novel 334 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1571317998
CA342388809
335 D>G No ClinGen
Ensembl
TCGA novel 336 V>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA342388868
rs1571321015
336 V>G No ClinGen
Ensembl
rs1571321038
CA342388872
337 K>E No ClinGen
Ensembl
rs1571321049
CA342388894
338 F>V No ClinGen
Ensembl
CA342388926
rs1571321064
339 W>L No ClinGen
Ensembl
rs1571321073
CA342388961
341 Q>P No ClinGen
Ensembl
TCGA novel 344 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1345822110
CA342389012
347 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1232408944
CA342389053
350 I>L No ClinGen
TOPMed
rs1309770487
CA342389094
353 V>I No ClinGen
TOPMed
rs1336093538
CA342389226
362 T>I No ClinGen
TOPMed
CA342389237
rs1414486859
363 L>P No ClinGen
TOPMed
TCGA novel 366 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 366 F>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 367 F>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1450581397
CA342389408
370 I>N No ClinGen
TOPMed
rs1390864390
CA342389508
377 N>I No ClinGen
TOPMed
rs1390864390
CA342389506
377 N>S No ClinGen
TOPMed
CA342389608
rs1383064201
385 Q>E No ClinGen
TOPMed
TCGA novel 386 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 387 M>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 388 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1405767511
CA342389701
389 M>T No ClinGen
TOPMed
CA342389829
rs1431622964
398 I>M No ClinGen
TOPMed
rs1390700022
CA342389835
399 R>* No ClinGen
TOPMed
CA342389838
rs1187442634
399 R>Q No ClinGen
TOPMed
rs1474122461
CA342389848
400 M>V No ClinGen
TOPMed
rs1248125572
CA342389950
406 Y>H No ClinGen
TOPMed
rs1199071684
CA342389964
407 R>H No ClinGen
TOPMed
rs1345007953
CA342390197
422 Y>C No ClinGen
TOPMed
CA342390215
rs1275937732
423 H>Y No ClinGen
TOPMed
TCGA novel 424 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA342390229
rs1214095301
424 R>H No ClinGen
TOPMed
rs1345113313
CA342390328
432 V>F No ClinGen
TOPMed
CA342390355
rs1411405134
434 A>T No ClinGen
TOPMed
rs1371129700
CA342390361
434 A>V No ClinGen
TOPMed
CA342390416
rs1407735604
438 I>M No ClinGen
TOPMed
rs1426587953
CA342390418
439 L>V No ClinGen
TOPMed
TCGA novel 442 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA342390645
rs1172801763
452 Q>E No ClinGen
TOPMed
CA342390697
rs1479942345
454 A>V No ClinGen
TOPMed
rs1266308131
CA342390701
455 P>A No ClinGen
TOPMed
CA342390719
rs1197773022
456 P>C No ClinGen
TOPMed

No associated diseases with P0CG08

2 regional properties for P0CG08

Type Name Position InterPro Accession
domain Golgi pH regulator, conserved domain 142 - 207 IPR022535
domain Abscisic acid G-protein coupled receptor-like domain 277 - 446 IPR025969

Functions

Description
EC Number
Subcellular Localization
  • Golgi apparatus membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
Golgi cisterna membrane The lipid bilayer surrounding any of the thin, flattened compartments that form the central portion of the Golgi complex.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

1 GO annotations of molecular function

Name Definition
voltage-gated anion channel activity Enables the transmembrane transfer of an anion by a voltage-gated channel. An anion is a negatively charged ion. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded.

4 GO annotations of biological process

Name Definition
intracellular pH reduction Any process that reduces the internal pH of a cell, measured by the concentration of the hydrogen ion.
protein transport The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
regulation of ion transmembrane transport Any process that modulates the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other.
T cell differentiation The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P38799 YHR078W Uncharacterized protein YHR078W Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q5BIM9 GPR89 Golgi pH regulator Bos taurus (Bovine) PR
Q5F448 GPR89 Golgi pH regulator Gallus gallus (Chicken) PR
B7ZAQ6 GPR89A Golgi pH regulator A Homo sapiens (Human) PR
Q8BS95 Gpr89 Golgi pH regulator Mus musculus (Mouse) PR
10 20 30 40 50 60
MSFLIDSSIM ITSQILFFGF GWLFFMRQLF KDYEIRQYVV QVIFSVTFAF SCTMFELIIF
70 80 90 100 110 120
EILGVLNSSS RYFHWKMNLC VILLILVFMV PFYIGYFIVS NIRLLHKQRL LFSCLLWLTF
130 140 150 160 170 180
MYFFWKLGDP FPILSPKHGI LSIEQLISRV GVIGVTLMAL LSGFGAVNCP YTYMSYFLRN
190 200 210 220 230 240
VTDTDILALE RRLLQTMDMI ISKKKRMAMA RRTMFQKGEV HNKPSGFWGM IKSVTTSASG
250 260 270 280 290 300
SENLTLIQQE VDALEELSRQ LFLETADLYA TKERIEYSKT FKGKYFNFLG YFFSIYCVWK
310 320 330 340 350 360
IFMATINIVF DRVGKTDPVT RGIEITVNYL GIQFDVKFWS QHISFILVGI IIVTSIRGLL
370 380 390 400 410 420
ITLTKFFYAI SSSKSSNVIV LLLAQIMGMY FVSSVLLIRM SMPLEYRTII TEVLGELQFN
430 440 450
FYHRWFDVIF LVSALSSILF LYLAHKQAPE KQMAP